Falling crude oil prices tempered enthusiasm for a greater than expected gain in May manufacturing activity. The markets traded mixed during the midday with the Dow slipping 15 points to 17,771 while Nasdaq rose 6 points to 4,954.
On the upside
Valeant Pharmaceuticals (NYSE: VRX) will report first quarter results on June 7, 2016.
Viking Therapeutics (NYSE: VKTX) chief executive Brian Lian, Ph.D. will present at the 2016 Marcum Microcap Conference this afternoon.
CombiMatrix (Nasdaq: CBMX) will begin accepting samples for pre-implantation genetic screening by next generation sequencing in mid-June.
On the downside
Daktronics (Nasdaq: DAKT) fell to a greater than expected loss for the fourth quarter as revenue dropped.
Adeptus Health (NYSE: ADPT) forecast second quarter results below analyst estimates and announced that it will offer 2.75 million shares of common stock.
ChemoCentryx (Nasdaq: CCXI) received Priority Medicines (PRIME) designation from the European Medicines Agency for CCX168 to treat ANCA-Associated Vasculitis but the stock price fell.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 held steady at 2,096. Bitcoin gained $7 to $529.
Mixed markets as investors weigh economic data
June 01, 2016 at 14:28 PM EDT
